Article

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - A review

Department of Nuclear Medicine, University of Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.
European Journal of Nuclear Medicine (Impact Factor: 5.38). 08/2011; 38(12):2269-81. DOI: 10.1007/s00259-011-1904-z
Source: PubMed

ABSTRACT

The impact on patients' health of radiopharmaceuticals in nuclear medicine diagnostics has not until now been evaluated systematically in a European context. Therefore, as part of the EU-funded Project PEDDOSE.NET ( www.peddose.net ), we review and summarize the current knowledge on biokinetics and dosimetry of commonly used diagnostic radiopharmaceuticals.
A detailed literature search on published biokinetic and dosimetric data was performed mostly via PubMed ( www.ncbi.nlm.nih.gov/pubmed ). In principle the criteria for inclusion of data followed the EANM Dosimetry Committee guidance document on good clinical reporting.
Data on dosimetry and biokinetics can be difficult to find, are scattered in various journals and, especially in paediatric nuclear medicine, are very scarce. The data collection and calculation methods vary with respect to the time-points, bladder voiding, dose assessment after the last data point and the way the effective dose was calculated. In many studies the number of subjects included for obtaining biokinetic and dosimetry data was fewer than ten, and some of the biokinetic data were acquired more than 20 years ago.
It would be of interest to generate new data on biokinetics and dosimetry in diagnostic nuclear medicine using state-of-the-art equipment and more uniform dosimetry protocols. For easier public access to dosimetry data for diagnostic radiopharmaceuticals, a database containing these data should be created and maintained.

Download full-text

Full-text

Available from: Manuel Bardiès
  • Source
    • "NaF PET/CT regained interest for bone scanning [6]. The kinetics of the radiopharmaceutical is quite useful for imaging. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim: To investigate the role of 18F-NaF PET/CT and compare it with 99m Tc-MDP whole body bone scintigraphy and 18F-FDG PET/CT in detecting the extent of metastatic bone disease and to present our first experience with 18F-NaF PET/CT in our country. Materials and methods: A total of 37 histopathologically proven cancer patients (22 male, 15 female) with bone metastasis detected on Tc-99m MDP whole body bone scan were prospectively enrolled Cebeci, following ethics committee approval. 18F-NaF PET/CT was performed to the participants in Ankara University Medical Faculty Nuclear Medicine Department for evaluation of symptomatic skeletal sites which were negative on Tc-99m MDP whole body bone scan. A lesion based comparison was made between 18F-NaF PET/CT and Tc-99m MDP whole body bone scan for each patient and between 18F-NaF PET/CT and 18F-FDG PET/CT in 12/37 patients. Results: The number of lesions demonstrated by 99m Tc-MDP bone scan and 18F-NaF PET/CT was equal in 4/37 (%11) of the cases. 18F-NaF PET/CT showed a greater number of pathological foci in 89% of participants. 18F-NaF PET/CT was able to show both lytic and blastic lesions and small lesions were better visualized due to the advantage of sectional imaging with much better resolution and higher target/background ratio. 18F-NaF PET/CT demonstrated a greater number of metastases in 10/12 (83%) of the patients when compared to 18F-FDG PET/CT. In the other two patients, bone metastasis could be demonstrated only by 18F-NaF PET/CT. The uptake of 18F-FDG was variable in blastic lesions and cranial bone involvement was missed by 18F-FDG PET/CT in some cases due to physiological brain metabolism. Conclusion: Although further prospective clinical studies in specific cancer populations are indicated to set the place of 18F-NaF PET/CT in diagnostic scheme, the results of this pilot study from our country support the superiority of 18F-NaF PET/CT in investigation of bone metastasis over 99mTc-MDP bone scan and 18F-FDG PET/CT in various malignancies. 18F-NaF PET/CT is coming forward as a single step bone seeking study, considering all the advantages, but especially potential of detecting occult metastases and reliably directing patient management.
    Full-text · Article · Sep 2015 · Journal of Bone Oncology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Im Gegensatz zur Positronenemissionstomographie/Computertomographie (PET/CT) sind die auf dem Markt angebotenen Single-photon-emission-computed-tomography/CT(SPECT/CT)-Systeme sehr heterogen. Auf der Seite der Gammakameras sind Zweikopfsysteme etabliert, die sich bei den verschiedenen Wettbewerbern nur unwesentlich unterscheiden. Hingegen reicht bei der CT-Komponente die Palette von der einfachen Niedrigdosisröntgenröhre über die flachdetektorbasierte Cone-beam-CT-Technologie bis hin zum Mehrzeilenspiral-CT. Die CT-Bilddaten werden dabei zum einen zur anatomischen Korrelation funktionell auffälliger Befunde verwendet, können aber auch für eine Schwächungskorrektur der SPECT-Daten herangezogen werden. Neben einer qualitativen Verbesserung der SPECT-Bilder eröffnet sich damit nunmehr die Möglichkeit der Quantifizierung der Radioaktivitätskonzentration. Moderne iterative Rekonstruktionsalgorithmen erlauben unter Verwendung der Dichteinformation aus den CT-Daten eine Streu- und Schwächungskorrektur der SPECT-Daten. Inwiefern sich die Sensitivität szintigraphischer Untersuchungen durch den Einsatz schwächungskorrigierter Ganzkörper-SPECT/CT-Aufnahmen erhöhen lässt, muss erst in entsprechenden Studien gezeigt werden. Da bei der SPECT/CT nicht das Auffinden zusätzlicher Radionuklidspeicherungen, sondern die morphologische und damit verbunden die artdiagnostische Zuordnung das primäre Ziel darstellt, sollte auf die Ausgewogenheit notwendiger morphologischer Information und erforderlicher zusätzlicher Strahlenexposition geachtet werden. Neben der SPECT-geführten CT sollten auch alle technischen Möglichkeiten der Dosisreduktion ausgeschöpft werden.
    No preview · Article · Jul 2012 · Der Radiologe

  • No preview · Article · Jan 2011 · Nuklearmedizin
Show more